CHARMAINE GONZALVO

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family HONOLULU, HI NPI 1457059537

General Payments — all program years on this page

$1,255.45

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 37
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $856.00 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $856.0022

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $399.4515
2024 $856.0022

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086345957 Bayer Healthcare Pharmaceuticals Inc. $17.55 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092742189 Boston Scientific Corporation $41.11 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092742191 Boston Scientific Corporation $139.04 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092742193 Boston Scientific Corporation $163.74 12/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104384619 AstraZeneca Pharmaceuticals LP $100.80 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105270409 AstraZeneca Pharmaceuticals LP $24.08 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105692041 AstraZeneca Pharmaceuticals LP $26.27 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105700546 AstraZeneca Pharmaceuticals LP $18.94 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107236360 ABBVIE INC. $29.40 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107236362 ABBVIE INC. $8.97 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107236364 ABBVIE INC. $12.25 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107236366 ABBVIE INC. $29.14 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107236368 ABBVIE INC. $22.27 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107236370 ABBVIE INC. $30.40 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114679077 Exact Sciences Corporation $26.86 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114679083 Exact Sciences Corporation $31.62 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115669647 Amgen Inc. $19.22 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115669655 Amgen Inc. $27.42 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115669665 Amgen Inc. $14.79 12/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115669673 Amgen Inc. $21.40 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135622327 Lilly USA, LLC $18.38 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154981894 Echosens North America, Inc. $32.35 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.